Showing results (231-240 of 242) with videos related to
Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|April 2, 2017
Changing epidemiology of candidaemia in AustraliaBelinda Chapman, Monica Slavin, Debbie Marriott, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2026
Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New ZealandChin Fen Neoh, Sharon C-A Chen, Arthur J Morris, et al.The Lancet Regional Health. Western Pacific|June 26, 2023
COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort studyVictoria G Hall, Beatrice Z Sim, Chhay Lim, et al.Journal of Fungi (Basel, Switzerland)|March 19, 2020
Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology PatientsJannik Stemler, Caroline Bruns, Sibylle C Mellinghoff, et al.Physical Review Letters|November 12, 2024
Toward the Discovery of New Elements: Production of Livermorium (Z=116) with ^{50}TiJ M Gates, R Orford, D Rudolph, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.Nature Genetics|November 16, 2002
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndromeJ D Carpten, C M Robbins, A Villablanca, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.The Lancet. Infectious Diseases|February 12, 2024
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASMChristina C Chang, Thomas S Harrison, Tihana A Bicanic, et al.Pageof 25